risankizumab
boehringer ingelheim,abbvie
['psoriatic arthritis', 'risan', 'keepsake 1']
an analysis of 100-week data from the keepsake 1 and 2 trials presented at #eular2023 offers insight into the long-term effects of risankizumab use in people with psoriatic arthritis. #artritis
HCPLive Cardiology provides clinically impactful news and updates for practitioners in cardiovascular medicine.